[Potential harms associated with 4-aminoquinoline treatment].
Copyright policy [Potential harms associated with 4-aminoquinoline treatment].
Hydroxychloroquine and chloroquine are currently being evaluated as treatment against COVID-19. These drugs are associated with some potential harms, including QTc-interval prolongation, hypoglycaemia, severe skin reactions and psychiatric effects. Use of hydroxychloroquine or chloroquine should be reserved to current indications or clinical trials, as recommended by several governmental medical products agencies.
- Skåne University Hospital Sweden
Antimalarials, Betacoronavirus, SARS-CoV-2, Pneumonia, Viral, Aminoquinolines, COVID-19, Humans, Chloroquine, Coronavirus Infections, Antiviral Agents, Pandemics, Hydroxychloroquine
Antimalarials, Betacoronavirus, SARS-CoV-2, Pneumonia, Viral, Aminoquinolines, COVID-19, Humans, Chloroquine, Coronavirus Infections, Antiviral Agents, Pandemics, Hydroxychloroquine
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!